Published online 10 March 2005
Methods Online |
A microarray configuration to quantify expression levels and relative abundance of splice variants
ExonHit Therapeutics 63/65 boulevard Masséna, 75013 Paris, France
*To whom correspondence should be addressed. Tel: +33 (0) 1 53 94 77 09; Fax: +33 (0) 1 53 94 77 15; Email: olivier.cochet{at}exonhit.com
Received December 23, 2004. Revised February 17, 2005. Accepted February 17, 2005.
Over the past decade, alternative RNA splicing has raised a great interest appearing to be of high importance in the generation of expression diversity. This regulatory process plays a critical role in the normal development and its impact on the initiation and development of human disorders as well as on the pharmacological properties of drugs is increasingly being recognized. Only few studies describe specific alternative splicing expression profiling. Microarray strategies have been conceived to address alternative splicing events but with very few experimental data related to their abilities to provide true quantification values. We have developed a specific microarray configuration relying on a few, well optimized probes per splice event. Basically, five probes of 24mer are used to fully characterize a splice event. These probes are of two types, exon probes and junction probes, and are either specific to a splice event or not. The performances of such a ‘splice array’ were validated on synthetic model systems and on complex biological materials. The results indicate that DNA chips based on this design combining exon and junction derived probes enable the detection and, absolute and relative quantification of splice variants. In addition, this strategy is compatible with all the microarrays that use oligonucleotide probes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Thorsen, K. D. Sorensen, A. S. Brems-Eskildsen, C. Modin, M. Gaustadnes, A.-M. K. Hein, M. Kruhoffer, S. Laurberg, M. Borre, K. Wang, et al. Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis Mol. Cell. Proteomics, July 1, 2008; 7(7): 1214 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Einstein, H. Jordan, W. Zhou, M. Brenner, E. G. Moses, and S. B. Liggett Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors PNAS, April 1, 2008; 105(13): 5230 - 5235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Novoyatleva, B. Heinrich, Y. Tang, N. Benderska, M. E.R. Butchbach, C. L. Lorson, M. A. Lorson, C. Ben-Dov, P. Fehlbaum, L. Bracco, et al. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing Hum. Mol. Genet., January 1, 2008; 17(1): 52 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. French, J. Peeters, S. Horsman, E. Duijm, I. Siccama, M. J. van den Bent, T. M. Luider, J. M. Kros, P. van der Spek, and P. A. Sillevis Smitt Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays Cancer Res., June 15, 2007; 67(12): 5635 - 5642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Florea Bioinformatics of alternative splicing and its regulation Brief Bioinform, March 1, 2006; 7(1): 55 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Milani, M. Fredriksson, and A.-C. Syvanen Detection of Alternatively Spliced Transcripts in Leukemia Cell Lines by Minisequencing on Microarrays Clin. Chem., February 1, 2006; 52(2): 202 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Noh, K. Lee, H. Paik, and C.-G. Hur TISA: Tissue-specific Alternative Splicing in Human and Mouse Genes DNA Res, January 1, 2006; 13(5): 229 - 243. [Abstract] [Full Text] [PDF]
|
|